Page 141 - Total Voting News Today

About Silence Therapeutics plc Silence Therapeutics is developing a new generation of medicines by harnessing the bodys natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet medical need. Silences proprietary technology can be used to engineer short interfering ribonucleic acids (siRNAs) that bind specifically to and silence, through the RNAi pathway, almost any gene in ...

  Provexis plc ("Provexis" or the "Company"), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow® heart-health functional food ingredient, announces its unaudited interim results for the six months ended 30 September 2020.     ·Total revenue for the period of £237k, 7% ahead of the prior year (2019: £222k) and an all-time high in the first half of the year for the Fruitflow business.   ·Planned launch by By-Health, a circa ...

  On 29 January 2021, Maven Income and Growth VCT 3 PLC (the Company) purchased, for cancellation, 250,000 of its own Ordinary Shares at 51p per share. As a result, and in accordance with the Financial Conduct Authoritys Disclosure Guidance and Transparency Rules, the Company confirms that its issued share capital as at close of business on 29 January 2021 comprises 79,403,579 Ordinary Shares of 10p each, with each share carrying one voting right. The above figure may...

Issue of Equity and Total Voting Rights Albion Venture Capital Trust PLC Issue of Equity and Total Voting Rights LEI CODE 213800JKELS32V2OK421 Albion Venture Capital Trust PLC (the "Company") announces that, further to the Dividend Reinvestment Scheme (details of which were set out in the Circular issued to shareholders on 10 July 2008), the Company allotted 329,463 ordinary shares of 1 penny each (the "new ordinary shares") in the capital of the Company on 29 January 2021. The new ordinary sh...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

  On 29 January 2021, Maven Income and Growth VCT PLC (the Company) purchased 467,539 of its own Ordinary Shares, for cancellation, at 40p per share.   As a result, and i n accordance with the Financial Conduct Authoritys Disclosure Guidance and Transparency Rules, the Company confirms that its issued share capital as at close of business on 29 January 2021   comprises 91,324,260 Ordinary Shares of 10p each, with each share carrying one voting rig...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

Oriole Resources PLC   Blytheweigh (IR/PR contact)   Grant Thornton UK LLP   Shard Capital Partners LLP       Oriole Resources PLC is an AIM-listed exploration company, operating West Africa. It is focused on early-stage exploration in Cameroon (Bibemi and Wapouzé projects) and the more advanced Senala gold project in Senegal, where IAMGOLD has the option to spend US$8...

  Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.   Byotrols products can be used stand-alone or as ingredients within existing products, where they can significan...